Tag: $BMRN

Sentiments dictate BioMarin and Salesforce.com

BMRN– BioMarin Pharmaceutical Inc evelops and commercializes pharmaceuticals for various diseases and medical conditions.

BMRN– BioMarin Pharmaceutical Inc

Fundamentals Previously closed at 89.65
Day’s high 91.26
Day’s low 88.94
P/E ratio NA
EPS -1.18

 

Analysts opinion BioMarin is a specialist in rare-disease specialist. The controversial drug Kyndrisa, which intended to treat Duchenne muscular dystrophy was rejected by the Committee for Medical Products for Human Use (CHMP). Analyst confidence meter, a proprietary algorithm of Stockal gives 89% buy based on analyst ratings.
Sentiments The sentiment index is 50% positive according to Stockal proprietary algorithm.
NA Media Pulse The stock has 64% higher social media chatter than usual.

Continue Reading…